Mestag was founded in 2020 by leading investigators and SV Health Investors to develop new medicines for people affected by inflammatory disease and cancer.

Biotechnology

Research

Mestag Therapeutics

Mestag Therapeutics' headquarters in London, United Kingdom

Susan Hill

Ray Jupp

Eilidh Goodwin

Patrice Love

Robert De Jonge

Neil Weir

Juliette Audet

Kate Bingham

Issi Rozen

Elizabeth M. Jaffee

Michael B. Brenner

Mark Coles

Theresa Podrebarac

Chris Buckley

Diana Bernstein

Fiona McLaughlin

Soumya Raychaudhuri

David A. Tuveson

Ton Logtenberg

Charles Dunn

Greg Elson

The Scientific Research team at Mestag Therapeutics is dedicated to advancing the discovery and development of novel medicines for inflammatory diseases and cancer. The team's focus includes antibody discovery, biological research, and translational science to identify and validate new therapeutic targets. This group of experts collaborates to drive innovative solutions from early-stage research to clinical development.

Scientific Research

The Board and Executives at Mestag Therapeutics are responsible for setting the strategic direction, overseeing company operations, making high-level decisions, and ensuring alignment with the company's mission to develop new medicines for inflammatory diseases and cancer. This team provides governance, seeks investment opportunities, and supports innovative research and development initiatives.

Board and Executives

The Advisory Team at Mestag Therapeutics comprises experts who provide strategic guidance and specialized knowledge to support the development of innovative medicines for inflammatory diseases and cancer. Their insights help shape research directions, regulatory strategies, and clinical development plans.

Advisory Team

The Leadership Team at Mestag Therapeutics is responsible for setting the strategic direction of the company, guiding research and development initiatives, and overseeing corporate operations. This team, comprised of top executives in scientific research, corporate development, and data science, collaborates to drive innovation in the development of new therapeutics for inflammatory diseases and cancer, ensuring alignment with the company's mission and goals.

Leadership Team

The Operations Team at Mestag Therapeutics ensures the seamless functioning of the company by managing projects, overseeing financial affairs, maintaining office administration, supporting HR functions, coordinating corporate development activities, and leading program initiatives. This team operates at the backbone of the company, enabling the development of new medicines for inflammatory diseases and cancer.

Operations Team

The Corporate Strategy and Development team at Mestag Therapeutics focuses on shaping the company's long-term vision and growth plans. This includes driving strategic partnerships, overseeing mergers and acquisitions, aligning organizational culture and talent strategies, and leveraging data science and target discovery to enhance the pipeline of new medicines for inflammatory diseases and cancer.

Mestag Therapeutics

Org chart

Board & advisors

Teams

Scientific Research

Board and Executives

Advisory Team

Leadership Team

Operations Team

Corporate Strategy and Development

Offices

Mestag Therapeutics

Org chart

Board & advisors

Teams

Scientific Research

Board and Executives

Advisory Team

Leadership Team

Operations Team

Corporate Strategy and Development

Offices

Related companies